Douangsone Vadysirisack
Corporate Officer/Principal presso DIANTHUS THERAPEUTICS, INC.
Profilo
Douangsone Vadysirisack is currently working as the Director-Biology at Ra Pharmaceuticals, Inc. and as the Vice President-Translational Biology at Dianthus Therapeutics, Inc. He holds a doctorate degree from The Ohio State University.
Posizioni attive di Douangsone Vadysirisack
| Società | Posizione | Inizio |
|---|---|---|
| DIANTHUS THERAPEUTICS, INC. | Corporate Officer/Principal | 11/09/2023 |
| RA PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
Formazione di Douangsone Vadysirisack
| The Ohio State University | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| DIANTHUS THERAPEUTICS, INC. | Health Technology |
| Aziende private | 1 |
|---|---|
Ra Pharmaceuticals, Inc.
 Ra Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Ra Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in the discovery and development of peptide-based drugs. It uses Extreme Diversity platform that allows to produce synthetic macrocyclic peptides. The company was founded by James W. Broderick and Douglas A. Treco on June 27, 2008 and is headquartered in Cambridge, MA. | Health Technology |
- Borsa valori
- Insiders
- Douangsone Vadysirisack